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The binding of radiolabelled 1251-CRP to human neutrophils has been characterised according to pH, tem- 
perature and time dependence. The binding of ‘251-CRP was saturable, very fast (< 2 min at 22”C), and 
the labelled protein was displaced by unlabelled CRP and aggregated human IgG. The dissociation constant 
was 3.2 x lOWE M at pH 7.4, 22°C and 8.8 x 10eE M at pH 6.0, 22°C. The calculated number of binding 
sites was 5 -20 x lo4 per cell at pH 7.4, 22°C. An association with an F,-type receptor is suggested, since 
aggregated IgG was able to displace specifically CRP. 
C-reactive protein; Neutrophil; Receptor 
1. INTRODUCTION 
Elevated amounts of C-reactive protein are 
found in human serum during the acute-phase 
response, as a result of inflammation and tissue in- 
jury [l]. Levels of CRP can increase from a me- 
dian level of less than 1 pg/ml by up to lOOO-fold 
in less than 48 h as a result of enhanced biosyn- 
thesis in liver hepatocytes which is mediated by a 
macrophage-derived factor suggested to be 
interleukin-1 [1,2]. CRP is characterized by its 
binding in a Ca2+-dependent manner to C- 
polysaccharide [3] and in particular to the ligand 
phosphocholine [4]. 
CRP has been found at sites of tissue lesion 
[5,6]. Neutrophilia and neutrophil migration into 
sites of inflammation and tissue injury is a com- 
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mon immune defense response [7]. Thus, studying 
the binding of CRP to neutrophils and its possible 
consequence on metabolic and functional activity 
of the cells would be of interest. Reports have in- 
dicated varying effects of CRP on neutrophil func- 
tion such as motility [8], secretion of enzymes [6] 
and phagocytosis of certain bacteria [9]. In the 
presence of the stimulant PMA, enhancement of 
phagocytosis of CRP and PC coated sheep 
erythrocytes by neutrophils suggested the possibili- 
ty of a specific cellular receptor for CRP [ 101. We 
have previously studied the effect of CRP on 
neutrophil functions, e.g. superoxide production, 
secretion, chemotaxis and phagocytosis [ 1 I], 
which glso suggested that CRP binds to a specific 
receptor. 
We have characterised several parifmeters of the 
interaction of CRP with human neutrophils at pH 
7.4 including saturation and competition binding, 
kinetics and temperature dependence with purified 
radiolabelled 1251-CRP. Since at sites of inflamma- 
tion the pH is found to be 6-7 [12], binding studies 
were also performed at pH 6.0. The possibility that 
CRP may compete with IgG for a F, type receptor 
was also investigated. 
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2. MATERIALS AND METHODS 
2.1. Purification of human C-reactive protein 
CRP was purified from pooled human sera 
using an affinity column of phosphoryl- 
ethanolamine-agarose (Sigma, St. Louis, MO) 
[ 131, followed by passage on a Sephadex G-200 
(Pharmacia, Uppsala) column [ 141. 
2.2. Iodination of CRP 
CRP was iodinated by the iodogen method ‘15’ 
with carrier-free Nalz51, and an Iodobead (Pierce, 
Rockwell, IL), and separated from the free iodine 
on a column of Sephadex G-25 (Pharmacia). The 
specific activity of various preparations was 
2-7 &i/pg. 
2.3. Neutrophils 
Neutrophils were isolated from human blood 
(Blood Bank, Jaffa, Israel) as described [16]. 
Preparations contained at least 95% neutrophils of 
at least 98% viability as found by exclusion of 
trypan blue or eosin Y. 
2.4. Binding assay 
Binding studies were performed at 4, 22 and 
37°C for 30, 20 and 15 min, respectively, at a final 
volume of 250~1 PBS, pH 7.4 or pH 6.0. Cells 
were incubated with gentle agitation in plastic 
tubes (Nunc, 70 x 12 mm, 3-5 x lo6 
neutrophils/tube) with “‘1-CRP (- 0.05 pg) 
together with various concentrations of unlabelled 
CRP. Incubations were terminated by rapidly 
Fig. 1. Specific binding of ‘251-CRP to human 
neutrophils at pH 7.4. 4°C (M), 22°C (M), 
37°C (0-a). 
diluting with 1.5 ml cold PBS, followed by cen- 
trifugation at 300 x g (Beckman TJ-6) for 7 min at 
4°C. The supernatant was discarded by aspiration 
and the pellet washed twice more with cold PBS. 
Non-specific binding was defined as the amount of 
binding not inhibited by 50 pug/ml of unlabelled 
CRP and was usually equal to about 40-50% of 
the total counts bound (22”C, pH 7.4). Specific 
binding was defined as the total amount of 12% 
CRP bound minus the non-specific binding. The 
binding referred to is that of specific binding. The 
1251-CRP was determined by counting in a Kontron 
MD-480 gamma counter, and all results are the 
means of triplicate determinations. 
3. RESULTS 
The specific saturation binding of ‘251-CRP at 
pH 7.4, and at 4, 22 and 37°C is shown in fig.1. 
Displacement of 12’1-CRP by increasing concentra- 
tions of CRP is shown in fig.2A. Scatchard 
analysis of the binding gave a dissociation constant 
of 3.2 x lo-’ M, at pH 7.4, 22”C, as determined 
from the Scatchard plot (fig.2A, inset). The 
number of binding sites per cell was 5-20 x 104. 
Displacement of 1251-CRP by CRP in the 
presence of 10 pg/ml heat-aggregated human IgG 
is shown in fig.2B. The displacement of 1251-CRF 
by increasing concentrations of heat-aggregatec 
human IgG is shown in fig.2B (inset). 
Kinetic studies at 37 and 22°C reveal very fast 
binding of ‘251-CRP, with complete saturation 
within 2 min, while at 4°C this occurs within 
5-10 min (fig.3). After reaching saturation, there 
is a decrease in the specific binding of CRP to 
about 70-90% of the maximal specific binding 
found. At pH 6.0, the degree of non-specific 
binding is reduced to less than 10% of the total 
binding. Saturation binding is observed at 4, 22 
and 37°C as shown in fig.4. Maximal displacement 
of 12’1-CRP by CRP at 22°C occurred at a higher 
concentration of CRP (fig.5). Scatchard analysis 
gave a dissociation constant of 8.8 x 10-s M 
(fig.5, inset). 
No significant change in the binding of 1251-CRP 
to neutrophils was observed when the cells were in- 
itially stimulated with either PMA or Con A. The 
presence of PC (CRP : PC, 1: 5) resulted in a small 
increase in the affinity of CRP binding, with a 
dissociation constant of 2.9 x lo-’ M. PC alone at 
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Fig.2. (A) Displacement of “‘1-CRP by CRP from 
neutrophils, pH 7.4, 22°C. Concentration of r2’I-CRP 
was 0.2-0.4pg/ml. (Inset) Scatchard plot. (B) 
Displacement of 12’1-CRP by CRP in the absence 
(w) or presence (M) of lOpg/ml heat- 
aggregated IgG from neutrophils, pH 7.4, 22°C. (Inset) 
Displacement of 12’I-CRP by various concentrations of 
heat-aggregated IgG. 
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Fig.3. Time course of specific binding of ‘251-CRP to 
neutrophils at 4°C (w), 22°C (O---O) and 37°C 
(M). Concentration of 12’1-CRP was 0.28 rg/ml. 
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Fig.4. Specific binding of “‘1-CRP at pH 6.0 to 
neutrophils at 4°C (M), 22°C (C--O) and 37°C 
(M). 
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Fig.5. Displacement of ‘251-CRP by CRP from 
neutrophils at pH 6.0, 22°C. (Inset) Scatchard plot. 
lOOO-times the concentration of lz51-CRP dis- 
placed less than 5% of specifically bound CRP 
(not shown). 
4. DISCUSSION 
The present results point to the existence of 
specific receptors for CRP on the human 
neutrophil cell surface. As a consequence of the 
specific association of CRP with these loci, a series 
of cellular functions is manifested [l I]. 
Based on the competition binding experiments 
with heat-aggregated IgG, it is suggested that the 
CRP receptors are related to the IgG receptors. 
Previous studies, though of not direct binding, 
have indicated association of CRP with F,-type 
receptors in other cells. In vitro studies with 
monocytes show that following complement fixa- 
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tion by CRP binding to a particulate ligand, the 
presence of both CRP and the fixed complement is 
required for the internalization of the immune 
complex by the monocytes [17]. Similarly, in vitro 
experiments with mouse macrophages uggest hat 
since phagocytosis of CRP bound to sheep red 
blood cells coated with antibody to surface antigen 
was inhibited by IgG, cell interaction occurs via the 
F,-type receptor [ 181. 
On completion of the present work, the binding 
of CRP to human neutrophils was also reported 
[19]. A dissociation constant of 10 x lo-’ M and 
l-3 x lo6 binding sites per cell at 37°C were 
found. Binding was detected, however, only in the 
presence of an additional factor found in heat- 
inactivated serum [19]. On the other hand, in our 
experiments no such factor was required for 
binding. Moreover, we find that saturable binding 
occurs at a CRP concentration of ~5 pg/ml, pH 
7.4, rather than - 30 pg/ml. The former concen- 
tration is within the range at which CRP exerts 
maximal enhancement several functions of 
stimulated neutrophils, including superoxide pro- 
duction, secretion, chemotaxis and phagocytosis. 
At higher CRP concentrations (> 20 pg/ml), an in- 
hibition of neutrophil function was observed [ 111. 
The results indicate that CRP binds to a specific 
receptor on the neutrophil surface, and which ap- 
pears to bear a relationship to the F, receptor. The 
occurrence of specific receptors for CRP on sur- 
faces of phagocytes and the consequent effect of 
protein-cell binding upon various cellular func- 
tions strongly support the notion that CRP is in- 
timately involved in defense mechanisms which are 
associated with inflammation. Further work on the 
characterization of the CRP receptor using 
isolated neutrophil membranes is in progress. 
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